Luyan Mu

733 total citations
20 papers, 383 citations indexed

About

Luyan Mu is a scholar working on Molecular Biology, Cancer Research and Genetics. According to data from OpenAlex, Luyan Mu has authored 20 papers receiving a total of 383 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Cancer Research and 6 papers in Genetics. Recurrent topics in Luyan Mu's work include Glioma Diagnosis and Treatment (6 papers), MicroRNA in disease regulation (5 papers) and Ferroptosis and cancer prognosis (4 papers). Luyan Mu is often cited by papers focused on Glioma Diagnosis and Treatment (6 papers), MicroRNA in disease regulation (5 papers) and Ferroptosis and cancer prognosis (4 papers). Luyan Mu collaborates with scholars based in China and United States. Luyan Mu's co-authors include Yuwen Song, Haitao Ge, Linchun Jin, Duane A. Mitchell, Paul Kubilis, Jianping Huang, Changlin Yang, Yifan Chang, Jiping Qi and Xuezhe Han and has published in prestigious journals such as Journal of Clinical Oncology, Free Radical Biology and Medicine and International Journal of Cancer.

In The Last Decade

Luyan Mu

19 papers receiving 379 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Luyan Mu China 12 188 137 107 106 83 20 383
Caihong Sun China 9 158 0.8× 95 0.7× 70 0.7× 128 1.2× 93 1.1× 17 379
Guo-Shi Lin China 10 183 1.0× 150 1.1× 164 1.5× 84 0.8× 56 0.7× 12 408
Yolanda Piña United States 13 255 1.4× 134 1.0× 89 0.8× 127 1.2× 76 0.9× 62 629
Yangzhi Qi China 12 162 0.9× 112 0.8× 99 0.9× 83 0.8× 79 1.0× 26 408
Mianfu Cao China 12 193 1.0× 116 0.8× 82 0.8× 141 1.3× 175 2.1× 17 436
Zhennan Tao China 11 218 1.2× 119 0.9× 87 0.8× 94 0.9× 64 0.8× 21 381
Xisong Liang China 14 243 1.3× 148 1.1× 80 0.7× 115 1.1× 156 1.9× 35 528
Shuo Xu China 11 268 1.4× 232 1.7× 97 0.9× 167 1.6× 184 2.2× 21 575
Alicia Lenzen United States 7 183 1.0× 77 0.6× 84 0.8× 133 1.3× 137 1.7× 25 437
Songshan Feng China 15 234 1.2× 132 1.0× 112 1.0× 90 0.8× 194 2.3× 27 534

Countries citing papers authored by Luyan Mu

Since Specialization
Citations

This map shows the geographic impact of Luyan Mu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luyan Mu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luyan Mu more than expected).

Fields of papers citing papers by Luyan Mu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luyan Mu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luyan Mu. The network helps show where Luyan Mu may publish in the future.

Co-authorship network of co-authors of Luyan Mu

This figure shows the co-authorship network connecting the top 25 collaborators of Luyan Mu. A scholar is included among the top collaborators of Luyan Mu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luyan Mu. Luyan Mu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Kan, et al.. (2025). Ferroptosis and low-grade Glioma: The breakthrough potential of NUAK2. Free Radical Biology and Medicine. 234. 203–219. 1 indexed citations
2.
Wang, Kan, et al.. (2024). Microvascular decompression for intermediate nerve neuralgia: a case report and literature review. Frontiers in Surgery. 11. 1350075–1350075.
3.
Mu, Luyan, et al.. (2023). Research progress on ferroptosis in gliomas (Review). Oncology Letters. 27(1). 36–36. 6 indexed citations
4.
Mu, Luyan, et al.. (2022). MicroRNA-489-3p aggravates neuronal apoptosis and oxidative stress after cerebral ischemia-reperfusion injury. Bioengineered. 13(6). 14047–14056. 13 indexed citations
6.
Mu, Luyan, et al.. (2019). MicroRNA‑9 enhances chemotherapy sensitivity of glioma to TMZ by suppressing TOPO II via the NF‑κB signaling pathway. Oncology Letters. 17(6). 4819–4826. 7 indexed citations
7.
Mu, Luyan, Yu Long, Changlin Yang, et al.. (2018). The IDH1 Mutation-Induced Oncometabolite, 2-Hydroxyglutarate, May Affect DNA Methylation and Expression of PD-L1 in Gliomas. Frontiers in Molecular Neuroscience. 11. 62 indexed citations
8.
Wang, Jiabin, Fenghua Liu, Haitao Ge, et al.. (2017). Identifying survival-associated modules from the dysregulated triplet network in glioblastoma multiforme. Journal of Cancer Research and Clinical Oncology. 143(4). 661–671. 22 indexed citations
9.
Mu, Luyan, Haitao Ge, Hongbo Bao, et al.. (2017). IDH1 R132H Mutation Is Accompanied with Malignant Progression of Paired Primary-Recurrent Astrocytic Tumours. Journal of Cancer. 8(14). 2704–2712. 11 indexed citations
10.
Mu, Luyan, Changlin Yang, Qiang Gao, et al.. (2017). CD4+ and Perivascular Foxp3+ T Cells in Glioma Correlate with Angiogenesis and Tumor Progression. Frontiers in Immunology. 8. 1451–1451. 41 indexed citations
11.
Yang, Changlin, Haitao Ge, Linchun Jin, et al.. (2017). CD70 as a critical mediator of tumor progression and immunosuppression in gliomas.. Journal of Clinical Oncology. 35(7_suppl). 18–18. 1 indexed citations
12.
Jin, Linchun, Haitao Ge, Changlin Yang, et al.. (2017). CD70 as a novel target of CAR-T-cell therapy for gliomas.. Journal of Clinical Oncology. 35(7_suppl). 148–148. 2 indexed citations
13.
Ge, Haitao, Luyan Mu, Linchun Jin, et al.. (2017). Tumor associated CD70 expression is involved in promoting tumor migration and macrophage infiltration in GBM. International Journal of Cancer. 141(7). 1434–1444. 63 indexed citations
14.
Gao, Qiang, et al.. (2015). S100B and ADMA in cerebral small vessel disease and cognitive dysfunction. Journal of the Neurological Sciences. 354(1-2). 27–32. 38 indexed citations
15.
Mu, Luyan, Hui Li, Jiabin Tang, et al.. (2015). Inhibition of SHP-2 promotes radiosensitivity in glioma. Molecular Medicine Reports. 12(3). 3563–3568. 2 indexed citations
16.
Song, Yuwen, Luyan Mu, Xuezhe Han, Xiaoqian Liu, & Songbin Fu. (2014). siRNA targeting stathmin inhibits invasion and enhances chemotherapy sensitivity of stem cells derived from glioma cell lines. Acta Biochimica et Biophysica Sinica. 46(12). 1034–1040. 18 indexed citations
17.
Song, Yuwen, et al.. (2013). MicroRNA-9 inhibits vasculogenic mimicry of glioma cell lines by suppressing Stathmin expression. Journal of Neuro-Oncology. 115(3). 381–390. 42 indexed citations
18.
Liu, Xiaoqian, Li Li, Xiangmei Chen, et al.. (2009). No Association between EGF +61 A/G Polymorphism and Increased Risk of Glioma. The International Journal of Biological Markers. 24(2). 77–82. 11 indexed citations
19.
Liu, Xiaoqian, Li Li, Xiangmei Chen, et al.. (2009). No association between EGF +61 A/G polymorphism and increased risk of glioma. The International Journal of Biological Markers. 24(2). 77–82. 13 indexed citations
20.
Mu, Luyan. (2007). Relationship between mutations in the ALOX5AP gene and ischemic stroke. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026